The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| ABRYX | PAAIX | ABRYX / PAAIX | |
| Total Expense Ratio | 1.16 | 1.83 | 63% |
| Annual Report Gross Expense Ratio | 1.21 | 1.92 | 63% |
| Fund Existence | 17 years | 24 years | - |
| Gain YTD | 22.830 | 11.210 | 204% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 953M | 10.9B | 9% |
| Annual Yield % from dividends | 2.90 | 7.95 | 36% |
| Returns for 1 year | 28.00 | 14.74 | 190% |
| Returns for 3 years | 41.43 | 37.23 | 111% |
| Returns for 5 years | 11.51 | 27.29 | 42% |
| Returns for 10 years | 35.20 | 90.78 | 39% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDM | 93.70 | 0.62 | +0.67% |
| First Trust Dow Jones Sel MicroCap ETF | |||
| XLII | 25.09 | 0.11 | +0.44% |
| State Street® IndstrlSelSectSPDR®PrmETF | |||
| CCOM | 23.87 | -0.05 | -0.21% |
| Simplify Chinese Cmdts Stgy No K-1 ETF | |||
| DVAL | 16.66 | -0.06 | -0.38% |
| BrandywineGLOBAL Dyn US Lrg Cap Val ETF | |||
| FTXH | 41.77 | -0.44 | -1.05% |
| First Trust Nasdaq Pharmaceuticals ETF | |||